Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 587-600

  Hirata, Hirokazu ^a   Takahashi, Atsushi ^a,b,c   Kobayashi, Susumu ^a   Yonehara, Shin ^a   Sawai, Hirofumi ^a   Okazaki, Toshiro ^a   Yamamoto, Kokichi ^a   Sasada, Masataka ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Japan Found of Aging and Health ^*

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA FRAGMENT; FAS ANTIGEN; NUCLEAR PROTEIN; PHOSPHATIDYLSERINE; PROTEINASE; SYNTHETIC PEPTIDE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

ANTIGENS, CD95; ANTIGENS, NUCLEAR; APOPTOSIS; AUTOANTIGENS; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CASPASES; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; MITOTIC SPINDLE APPARATUS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; OLIGOPEPTIDES;

EID: 0032536519     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.587     Document Type: Article

References (79)

1. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-363.
2. Abbas, A.K. 1996. Die and let live: eliminating dangerous lymphocytes. Cell. 84:655-657.
3. Rathmell, J.C., S.E. Townsend, J.C. Xu, R.A. Flavell, and C.C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell. 87:319-329.
4. Alnemri E.S., D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell. 87:171.
5. Xiang, J., D.T. Chao, and S.J. Korsmeyer. 1996. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:14559-14563.
6. Longthorne, V.L., and G.T. Williams. 1997. Caspase activity is required for commitment to Fas-, mediated apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 16:3805-3812.
7. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science. 267:1449-1456.
8. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
9. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:803-815.
10. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
11. Medema, J.P., C. Scaffidi, F.C. Kischkel, A. Shevchenko, M. Mann, P.H. Krammer, and M.E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO (Eur. Mol. Biol. Organ.) J. 16:2794-2804.
12. Srinivasula, S.M., M. Ahmad, T. Fernandes-Alnemri, G. Litwack and E.S. Alnemri. 1996. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA. 93:14486-14491.
13. Muzio, M., G.S. Salvesen, and V.M. Dixit. 1997. FLICE induced apoptosis in a cell-free system - cleavage of caspase zymogens. J. Biol. Chem. 272:2952-2956.
14. Takahashi, A., H. Hirata, S. Yonehara, Y. Imai, K.K. Lee, R.W. Moyer, P.C. Turner, P.W. Mesner, T. Okazaki, H. Sawai, et al. 1997. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene. 14:2741-2752.
15. Boise, L.H., and C.B. Thompson. 1997. Bcl-x (L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:3759-3764.
16. Liu, X.S., H. Zou, C. Slaughter, and X.D. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:175-184.
17. Takahashi, A., E.S. Alnemri, Y.A. Lazebnik, T. Fernandes-Alnemri, G. Litwack, R.D. Moir, R.D. Goldman, G.G. Poirier, S.H. Kaufmann, and W.C. Earnshaw. 1996. Cleavage of lamin A by Mch2α but not CPP32: multiple ICE-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA. 93:8395-8400.
18. Martin, S.J., D.M. Finucane, G.P. Amarante-Mendes, G.A. O'Brien, and D.R. Green. 1996. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:28753-28756.
19. Webb, S.J., D.J. Harrison, and A.H. Wyllie. 1997. Apoptosis: an overview of the process and its relevance in disease. In Apoptosis: Pharmacological Implications and Therapeutic Opportunities. S.H. Kaufmann, editor. Academic Press, San Diego. 1-34.
20. Rotonda, J., D.W. Nicholson, K.M. Fazil, M. Gallant, Y. Gareau, M. Labelle, E.P. Peterson, D.M. Rasper, R. Ruel, J.P. Vaillancourt, et al. 1996. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 3:619-625.
21. Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1-16.
22. Nicholson, D.W., and N.A. Thornberry. 1997. Caspases: killer proteases. TIBS (Trends. Biochem. Sci.). 22:299-306.
23. Martin, S.J., and D.R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:349-352.
24. Orth, K., K. O'Rourke, G.S. Salvesen, and V.M. Dixit. 1996. Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J. Biol. Chem. 271:20977-20980.
25. Fernandes-Alnemri, T., R.C. Armstrong, J. Krebs, S.M. Srinivasula, L. Wang, F. Bullrich, L.C. Fritz, J.A. Trapani, K. Tomaselli, G. Litwack, and E.S. Alnemri. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:7464-7469.
26. Srinivasula, S.M., T. Fernandes-Alnemri, J. Zangrilli, N. Robertson, R. Armstrong, L. Wang, J.A. Trapani, K.J. Tomaselli, G. Litwack, and E.S. Alnemri. 1996. The Ced-3/interleukin 1β converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32. J. Biol. Chem. 271:27099-27106.
27. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:723-726.
28. Thornberry, N.A., E.P. Peterson, J.J. Zhao, A.D. Howard, P.R. Griffin, and K.T. Chapman. 1994. Inactivation of interleukin-1β converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry. 33:3934-3940.
29. Martins, L.M., T. Kottke, P.W. Mesner, G.S. Basi, S. Sinha, N.J. Frigon, E. Tatar, J.S. Tung, K. Bryant, A. Takahashi, et al. 1997. Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 human leukemia cells during etoposide-incluced apoptosis. J. Biol. Chem. 272:7421-7430.
30. Faleiro, L., R. Kobayashi, H. Fearnhead, and Y. Lazebnik. 1997. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO (Eur. Mol. Biol. Organ.) J. 16:2271-2281.
31. Clayton, L.K., Y. Ghendler, E. Mizoguchi, R.J. Patch, T.D. Ocain, K. Orth, A.K. Bhan, V.M. Dixit, and E.L. Reinherz. 1997. T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection. EMBO (Eur. Mol. Biol. Organ.) J. 16:2282-2293.
32. Zhou, Q., S. Snipas, K. Orth, M. Muzio, V.M. Dixit, and G.S. Salvesen. 1997. Target protease specificity of the viral serpin CrmA - analysis of five caspases. J. Biol. Chem. 272: 7797-7800.
33. Datta, R., H. Kojima, D. Banach, N.J. Bump, R.V. Talanian, E.S. Alnemri, R.R. Weichselbaum, W.W. Wong, and D.W. Kufe. 1997. Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272:1965-1969.
34. Kamada, S., Y. Funahashi, and Y. Tsujimoto. 1997. Caspase-4 and caspase-5, members of the ICE/CED-3 family of cysteine proteases, are CrmA-inhibitable proteases. Cell Death Diff. 4:473-478.
35. Chinnaiyan, A.M., K. Orth, K. O'Rourke, H. Duan, G.G. Poirier, and V.M. Dixit. 1996. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271:4573-4576.
36. MacFarlane, M., K. Cain, X.M. Sun, E.S. Alnemri, and G.M. Cohen. 1997. Processing/activation of at least four interleukin-1 beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol. 137:469-479.
37. Lazebnik, Y.A., S. Cole, C.A. Cooke, W.G. Nelson, and W.C. Earnshaw. 1993. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 123:7-22.
38. Yang, C.H., E.J. Lambie, and M. Snyder. 1992. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J. Cell Biol. 116:1303-1317.
39. Takahashi, A., E.S. Alnemri, T. Fernandes-Alnemri, Y.A. Lazebnik, R.D. Moir, R.D. Goldman, G.G. Poirier, S.H. Kaufmann, and W.C. Earnshaw. 1997. Biochemical dissection of nuclear events in apoptosis. In Cell Cycle Regulation. B. Metcalf, R.R.J. Ruffolo, and G. Poste, editors. Harwood Academic Publishers, Berks, UK. 131-149.
40. Kamada, S., M. Washida, J. Hasegawa, H. Kusano, Y. Funahashi, and Y. Tsujimoto. 1997. Involvement of caspase-4 (-like) protease in Fas-mediated apoptotic pathway. Oncogene. 15: 285-290.
41. Liu, X., C.N. Kim, J. Pohl, and X. Wang. 1996. Purification and characterization of an interleukin-1β-converting enzyme family protease that activates cysteine protease P32 (CPP32). J. Biol. Chem. 271:13371-13376.
42. Ghayur, T., M. Hugunin, R.V. Talanian, S. Ratnofsky, C. Quinlan, Y. Emoto, P. Pandey, R. Datta, Y.Y. Huang, S. Kharbanda, et al. 1996. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:2399-2404.
43. Han, Z.Y., E.A. Hendrickson, T.A. Bremner, and J.H. Wyche. 1997. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J. Biol. Chem. 272:13432-13436.
44. Slee, E.A., H. Zhu, S.C. Chow, M. MacFarlane, D.W. Nicholson, and G.M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21-24.
45. Greidinger, E.L., D.K. Miller, T.T. Yamin, R.L. Casciola, and A. Rosen. 1996. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett. 390: 299-303.
46. Casiano, C.A., S.J. Martin, D.R. Green, and E.M. Tan. 1996. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J. Exp. Med. 184:765-770.
47. Gueth-Hallonet, C., K. Weber, and M. Osborn. 1997. Cleavage of the nuclear matrix protein NuMA during apoptosis. Exp. Cell Res. 233:21-24.
48. Duan, H., A.M. Chinnaiyan, P.L. Hudson, J.P. Wing, W.-W. He, and V.M. Dixit. 1996. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271:1621-1625.
49. Krajewska, M., H.G. Wang, S. Krajewski, J.M. Zapata, A. Shabaik, R. Gascoyne, and J.C. Reed. 1997. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57:1605-1613.
50. Nakagawara, A., Y. Nakamura, H. Ikeda, T. Hiwasa, K. Kuida, M.S.-S. Su, H. Zhao, A. Cnaan, and S. Sakiyama. 1997. High levels of expression and nuclear localization of interleukin-1β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res. 57:4578-4584.
51. Lazebnik, Y.A., A. Takahashi, R. Moir, R. Goldman, G.G. Poirier, S.H. Kaufmann, and W.C. Earnshaw. 1995. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92:9042-9046.
52. Takahashi, A., P.-Y. Musy, L.M. Martins, G.G. Poirier, P.C. Turner, R.W. Moyer, and W.C. Earnshaw. 1996. CrmA/SPI-2 inhibition of an endogenous ICE-related protease responsible for lamin A cleavage and apoptotic nuclear fragmentation. J. Biol. Chem. 271:32487-32490.
53. Takahashi, A., P.J. Goldschmidt-Clermont, E.S. Alnemri, T. Fernandes-Alnemri, K. Yoshizawa-Kumagaya, K. Nakajima, M. Sasada, G.G. Poirier, and W.C. Earnshaw. 1997. Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. Exp. Cell Res. 231:123-131.
54. Rudel, T., and G.M. Bokoch. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 276:1571-1574.
55. Kroemer, G., P. Petit, N. Zamzami, J.L. Vayssiere, and B. Mignotte. 1995. The biochemistry of programmed cell death. FASEB J. 9:1277-1287.
56. Kroemer, G., N. Zamzami, and S.A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today. 18:44-51.
57. Susin, S.A., N. Zamzami, M. Castedo, E. Daugas, H.G. Wang, S. Geley, F. Fassy, J.C. Reed, and G. Kroemer. 1997. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-mduced apoptosis. J. Exp. Med. 186: 25-37.
58. Fadok, V. A., D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
59. Emoto, K., N. Toyama-Sorimachi, H. Karasuyama, K. Inoue, and M. Umeda. 1997. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res. 232: 430-434.
60. Vayssiere, J.L., P.X. Petit, Y. Risler, and B. Mignotte. 1994. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA. 91:11752-11756.
61. Martin, S.J., C.P. Reutelingsperger, A.J. McGahon, J.A. Rider, R.C. van Schie, D.M. LaFace, and D.R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression ot Bcl-2 and Abl. J. Exp. Med. 182:1545-1556.
62. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129-1132.
63. Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
64. Chinnaiyan, A.M., K. O'Rourke, B.R. Lane, and V.M. Dixit. 1997. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science. 273:1122-1126.
65. Kuida, K., T.S. Zheng, S. Na, C.-Y. Kuan, D. Yang, H. Karasuyama, P. Rakic, and R.A. Flavell. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:368-372.
66. Fernandes-Alnemri, T., A. Takahashi, R. Armstrong, J. Krebs, L. Fritz, K.J. Tomaselli, L. Wang, Z. Yu, C.M. Croce, G. Salveson, et al. 1995. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55:6045-6052.
67. Earnshaw, W.C. 1995. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7:337-343.
68. Verhoven, B., R.A. Schlegel, and P. Williamson. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1597-1601.
69. Zhou, Q.S., J. Zhao, J.G. Stout, R.A. Luhm, T. Wiedmer, and P.J. Sims. 1997. Molecular cloning ot human plasma membrane phospholipid scramblase - a protein mediating transbilaver movement of plasma membrane phospholipids. J. Biol. Chem. 272:18240-18244.
70. Casciola-Rosen, L.A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317-1330.
71. Toyoshima, F., T. Moriguchi, and E. Nishida. 1997. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like protease. J. Cell Biol. 139:1005-1015.
72. Talanian, R.V., C. Quinlan, S. Trautz, M.C Hackett, J.A. Mankovich, D. Banach, T. Ghayur, K.D. Brady, and W.W. Wong. 1997. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677-9682.
73. Thornberry, N.A., T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S. Roy, J.P. Vaillancourt, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B - functional, relationships established for key mediator of apoptosis J. Biol. Chem. 272:17907-17911.
74. Pai, J.-T., M.S. Brown, and J.L. Goldstein. 1996. Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA. 93:5437-5442.
75. Antosson, B., F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J.-J. Mermod, G. Mazzei, et al. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:370-372.
76. Susin, S.A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.
77. Takahashi, A., and W.C. Earnshaw. 1997. In vitro systems for the study of apoptosis. In Apoptosis: Pharmacological Implications and Therapeutic Opportunities. S.H. Kaufmann, editor. Academic Press, San Diego. 89-106.
78. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
79. Fisher, D.E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:539-542.